Real-world incidence of inflammatory bowel disease among patients with other chronic inflammatory diseases treated with interleukin-17a or phosphodiesterase 4 inhibitors

ACG Clinical Guideline: Management of Crohn’s Disease in Adults

(2018) Gary R Lichtenstein et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Cytokine targeting in rheumatoid arthritis

(2018) Viet L. Bui et al.   CLINICAL IMMUNOLOGY

Inflammatory bowel disease events after exposure to the IL-17 inhibitors, secukinumab and ixekizumab: A post-marketing analysis from the RADAR (Research on Adverse Drug events And Reports) Program

(2018) Kelsey A. Orrell et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Efficacy and Safety of Ixekizumab in Patients with Active Psoriatic Arthritis: 52-week Results from a Phase III Study (SPIRIT-P1)

(2017) Désirée van der Heijde et al.   JOURNAL OF RHEUMATOLOGY

Inflammatory bowel disease among patients with psoriasis treated with ixekizumab: A presentation of adjudicated data from an integrated database of 7 randomized controlled and uncontrolled trials

(2017) Kristian Reich et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Current and emerging therapeutic targets for IBD

(2017) Markus F. Neurath   Nature Reviews Gastroenterology & Hepatology

Association between psoriasis and inflammatory bowel disease: a Danish nationwide cohort study

(2016) A. Egeberg et al.   BRITISH JOURNAL OF DERMATOLOGY

Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis

(2016) Kenneth B. Gordon et al.   NEW ENGLAND JOURNAL OF MEDICINE

Cytokines in psoriasis

(2015) Jaymie Baliwag et al.   CYTOKINE

Psoriasis and Inflammatory Bowel Disease: Two Sides of the Same Coin?

(2015) Gionata Fiorino et al.   Journal of Crohns & Colitis

Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis

(2015) Dominique Baeten et al.   NEW ENGLAND JOURNAL OF MEDICINE

Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis

(2015) Mark Lebwohl et al.   NEW ENGLAND JOURNAL OF MEDICINE

Secukinumab Inhibition of Interleukin-17A in Patients with Psoriatic Arthritis

(2015) Philip J. Mease et al.   NEW ENGLAND JOURNAL OF MEDICINE

Secukinumab in Plaque Psoriasis — Results of Two Phase 3 Trials

(2014) Richard G. Langley et al.   NEW ENGLAND JOURNAL OF MEDICINE

Long-term safety and efficacy of etanercept in the treatment of ankylosing spondylitis

(2013) José Miguel Senabre-Gallego et al.   Patient Preference and Adherence

Psoriasis, psoriatic arthritis and increased risk of incident Crohn's disease in US women

(2012) Wen-Qing Li et al.   ANNALS OF THE RHEUMATIC DISEASES

Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial

(2012) Wolfgang Hueber et al.   GUT

Induction or exacerbation of psoriatic lesions during anti-TNF-α therapy for inflammatory bowel disease: A systematic literature review based on 222 cases

(2012) Rafael Denadai et al.   Journal of Crohns & Colitis

Th17-related cytokines: new players in the control of chronic intestinal inflammation

(2011) Ivan Monteleone et al.   BMC Medicine

Pervasive Sharing of Genetic Effects in Autoimmune Disease

(2011) Chris Cotsapas et al.   PLoS Genetics

Ulcerative Colitis Practice Guidelines in Adults: American College of Gastroenterology, Practice Parameters Committee

(2010) Asher Kornbluth et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Linking Crohn's Disease and Ankylosing Spondylitis: It's All about Genes!

(2010) Dirk Elewaut   PLoS Genetics

Psoriasis associated with ulcerative colitis and Crohn's disease

(2009) AD Cohen et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

A selective phosphodiesterase 4 (PDE4) inhibitor Zl-n-91 suppresses IL-17 production by human memory Th17 cells

(2008) Ruihong Ma et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Guidelines of care for the management of psoriasis and psoriatic arthritis

(2008) Alan Menter et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Induction and effector functions of TH17 cells

(2008) Estelle Bettelli et al.   NATURE